Preparation and characterization of gatifloxacin-loaded alginate/poly (vinyl alcohol) electrospun nanofibers
Source abstract
Abstract
The aim of this study was to develop novel biomedicated electrospun nanofibers for controlled release. Pre-formulation studies were carried out for nanofibers of sodium alginate (SA) (2 wt %)/polyvinyl alcohol (PVA) (10 wt %) composites (2/8, 3/7 and 4/6), by an electrospinning technique. The morphology and average diameter of the nanofibers were investigated by scanning electron microscopy (SEM). The optimum ratio (3/7) was used to load gatifloxacin hydrochloride (GH) (1wt %), found to form smooth fibers with uniform structures. The drug entrapment in the composite nanofibers was confirmed by SEM, X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), thermo gravimetric analysis (TGA), differential scanning calorimetry (DSC), and swelling behavior. The drug release behavior was investigated using phosphate-buffered saline (PBS) (pH 7.4) at 37°C for 24 h. The XRD and FTIR data demonstrate that there are good interactions between PVA and SA, possibly caused by hydrogen bonds. As much as 90% of the GH was released from the electrospun fibers within 6 h of incubation. Beyond this, the release was sustained for 24 h. The thickness of nanofibers greatly influenced the initial release and rate of drug release. Moreover, GH-loaded sodium alginate/PVA composite nanofibers exhibited a useful and convenient method for electrospinning in order to control the rate and period of drug release in wound-healing applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Graphene and Nanomaterials Applications · Polymer Nanocomposite Synthesis and Irradiation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (17)
Show source-provided references
1. 10.3109/0363904850905686910.3109/03639048509056869 ↗
2. Bhardwaj N · Electrospinning: a fascinating fiber fabrication technique, Biotechnol Adv · 2010 · 28 · 325
3. Caykara T · J Macromol Sci A · 2006 · 43 · 111310.1080/10601320600740389 ↗
4. Fish DN · Pharmacother · 2001 · 21 · 3510.1592/phco.21.1.35.34440 ↗
5. 10.3109/10717544.2014.91867610.3109/10717544.2014.918676 ↗
6. 10.1016/j.jconrel.2014.04.01810.1016/j.jconrel.2014.04.018 ↗
7. Jannesari M · Int J Nanomed · 2011 · 6 · 993
8. 10.1016/j.ijpharm.2014.04.04710.1016/j.ijpharm.2014.04.047 ↗
9. 10.1016/j.msea.2007.01.03910.1016/j.msea.2007.01.039 ↗
10. 10.1016/j.addr.2009.07.00610.1016/j.addr.2009.07.006 ↗
11. 10.1088/1748-6041/1/2/00110.1088/1748-6041/1/2/001 ↗
12. 10.1080/1558372080202218210.1080/15583720802022182 ↗
13. 10.1016/j.ijbiomac.2011.04.00510.1016/j.ijbiomac.2011.04.005 ↗
14. 10.1016/j.matlet.2013.08.10010.1016/j.matlet.2013.08.100 ↗
15. 10.1021/bm801033f10.1021/bm801033f ↗
16. Yu H · J Appl Polym Sci · 2006 · 101 · 245310.1002/app.23344 ↗
17. 10.1007/s00396-006-1630-410.1007/s00396-006-1630-4 ↗